Melissa Calise

In spite of COVID-19 and its impact on many of our programs, we have continued to focus our efforts on a variety of initiatives and have made great strides.

Alexes’ experience is both interesting and complicated. She lives with rare debilitating types of migraine. The presentation of symptoms impacts her daily life, including loss of fine motor skills, insufferable pain in her head and body and aphasia.

Lindsay had chronic daily migraine from her earliest memory (around the age of 3 or 4) until she was 30. She inherited the disease from her father. Years of daily migraine led her to develop complex regional pain syndrome (a constant pain like burning fire down to her bones) on the right side of her face, head, neck, and down her right arm. She was underweight throughout most of her twenties due to severe nausea and vomiting caused by migraine attacks. She even experienced a migraine-related seizure that stopped her breathing. She is currently episodic.

June wasn’t the only month to pay special attention to migraine and headache in 2020. In November, the Association of Migraine Disorders launched its first-ever Research Is Hope campaign to raise $200,000 for innovative research that aims to improve migraine patient care. A generous supporter offered to match up to $100,000 in donations until the end of the year.

Molly tells us about recent migraine research findings on Botox during pregnancy, exercise and behavioral therapy for migraine.

Migraine entered my life in college and grew progressively until it ultimately ended my career. The life I had carefully built over several decades crumbled as migraine made a career focused on deadlines, schedules, and meetings impossible to maintain.

Molly joins us to discuss new FDA approvals, a campaign to raise $200,000 for migraine research, and a treatment option now covered by insurance.

I dealt with menstrual headaches as a teenager, but nothing like the pain I started to experience while serving in Riyadh, Saudi Arabia in December 1990.

The Association of Migraine Disorders (AMD) has launched its “Research is Hope” campaign to raise money for innovative research that aims to improve patient care. A generous supporter will match up to $100,000 in donations made until the end of the year. The campaign shares five unique stories of people whose lives have been drastically changed by migraine. 

Magnesium has a great reputation as a safe and effective supplement that can help to reduce the frequency of migraine attacks when taken preventively, as well as potentially relieve symptoms during an attack when taken as needed,” Dr. Frederick Godley, MD, an otolaryngologist and the president of the Association of Migraine Disorders, says.

A great deal of attention has been paid to food triggers because unlike the other categories of triggers, we have complete control over the foods we eat,” says Dr. Michael Teixido, the co-founder and vice president of the Association of Migraine Disorders.

Molly shares the status of two pipeline migraine treatments, Timolol and Qtrypta. She also recaps findings from a study The Headache and Migraine Policy Forum performed on how the pandemic is impacting migraine patients.

The Association of Migraine Disorders recaps their annual Migraine Symposium.

Molly joins us again to recap three news updates you need to know about. Hear about a treatment method now available without a prescription, research on combination therapy and a potential new preventive medication.

Today, Molly is recapping findings from new research by the Cleveland Clinic, the NYU College of Dentistry and Amgen.

Can a person’s sexual orientation impact their risk of migraine? What new medications are on the horizon? Are occipital nerve stimulators an effective treatment for new daily persistent headache with migraine features? Molly O’Brien reports on recent news that will answer these questions.

Molly O’Brien gives an update on research findings by Harvard, a new app from Ctrl M Health and developments by Salvia Bioelectronics.

More than 39 million Americans live with migraine, yet the average medical professional only receives 1 hour of medical training on this disease during medical school. The Association of Migraine Disorders is on a mission to change this with its live, one-day, educational lecture series which will be held virtually at MigraineSymposium.org on October 3, 2020.

See the impact that one of the world’s largest migraine awareness campaigns made.

Shades for Migraine, an international awareness campaign, is asking participants to take their support for people with migraine one step further by signing and sharing a petition urging healthcare payors to provide better access to life-changing migraine treatments by eliminating barriers like step-therapy and high copays.

The Association of Migraine Disorders launches a comprehensive, online, continuing education course on the diagnosis and treatment of migraine.